emma craythorne

Dr. emma craythorne

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HFHiva Fassihi
Hiva Fassihi
MSMieran Sethi
Mieran Sethi
HFHeather Fawcett
Heather Fawcett
JWJonathan Wing
Jonathan Wing
NCNatalie Chandler
Natalie Chandler
ALAlan R. Lehmann
Alan R. Lehmann
Significance: Xeroderma pigmentosum (XP) is a genetic disorder caused by defective repair of DNA damage. Affected patients are mutated in one of eight genes and develop skin pigmentation changes, skin cancers, ocular surface abnormalities, and, in some cases, acute sunburn and neurodegeneration. The XP proteins are involved in different steps in the repair of DNA damage. Examination of 89 patients, the largest reported cohort under long-term follow-up, by the same multidisciplinary team of clinicians and scientists has revealed unexpected clinical heterogeneity dependent on the affected gene and the exact mutation. Our findings provide new insights into the mechanisms of carcinogenesis, ocular surface disease, and neurodegeneration, as well as providing improved clinical management and more definitive prognostic predictions.

23 October 2019 in Cold Spring Harbor Molecular Case Studies
Verified
Journal Article
Open access
PDF file
SMSophie Momen
Sophie Momen
HFHiva Fassihi
Hiva Fassihi
HDHelen R. Davies
Helen R. Davies
CNChristos Nikolaou
Christos Nikolaou
ADAndrea Degasperi
Andrea Degasperi
SNSerena Nik-Zainal
Serena Nik-Zainal
“Mutational signatures” are patterns of mutations that report DNA damage and subsequent repair processes that have occurred. Whole-genome sequencing (WGS) can provide additional information to standard diagnostic techniques and can identify therapeutic targets. A 32-yr-old male with xeroderma pigmentosum developed metastatic angiosarcoma that was unresponsive to three lines of conventional sarcoma therapies. WGS was performed on his primary cancer revealing a hypermutated tumor, including clonal ultraviolet radiation-induced mutational patterns (Signature 7) and subclonal signatures of mutated DNA polymerase epsilon (POLE) (Signature 10). These signatures are associated with response to immune checkpoint blockade. Immunohistochemistry confirmed high PD-L1 expression in metastatic deposits. The anti-PD-1 monoclonal antibody pembrolizumab was commenced off-label given the POLE mutation and high mutational load. After four cycles, there was a significant reduction in his disease with almost complete resolution of the metastatic deposits. This case highlights the importance of WGS in the analysis, interpretation, and treatment of cancers. We anticipate that as WGS becomes integral to the cancer diagnostic pathway, treatments will be stratified to the individual based on their unique genomic and/or transcriptomic profile, enhancing classical approaches of histologically driven treatment decisions.

29 June 2020 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
ADA. Durack
A. Durack
SGS. Gran
S. Gran
MGM D Gardiner
M D Gardiner
AJA. Jain
A. Jain
ECemma craythorne
emma craythorne
BWB.E. Wright
B.E. Wright

23 December 2015 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
AKA.C. Kai
A.C. Kai
TRT. Richards
T. Richards
ACA. Coleman
A. Coleman
RMR. Mallipeddi
R. Mallipeddi
RBR. Barlow
R. Barlow
ECemma craythorne
emma craythorne

24 October 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
MLM. D. Lynch
M. D. Lynch
CLC. N. S. Lynch
C. N. S. Lynch
ECemma craythorne
emma craythorne
KLK. Liakath-Ali
K. Liakath-Ali
RMR. Mallipeddi
R. Mallipeddi
FWF. M. Watt
F. M. Watt
Deep sequencing can detect somatic DNA mutations in tissues permitting inference of clonal relationships. This has been applied to human epidermis, where sun exposure leads to the accumulation of mutations and an increased risk of skin cancer. However, previous studies have yielded conflicting conclusions about the relative importance of positive selection and neutral drift in clonal evolution. Here, we sequenced larger areas of skin than previously, focusing on cancer-prone skin spanning five decades of life. The mutant clones identified were too large to be accounted for solely by neutral drift. Rather, using mathematical modelling and computational lattice-based simulations, we show that observed clone size distributions can be explained by a combination of neutral drift and stochastic nucleation of mutations at the boundary of expanding mutant clones that have a competitive advantage. These findings demonstrate that spatial context and cell competition cooperate to determine the fate of a mutant stem cell.

1 November 2011 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
ECemma craythorne
emma craythorne
GMGhulam Mufti
Ghulam Mufti
ADAnthony W. Duvivier
Anthony W. Duvivier